ResMed Announces Participation in the 17th Annual Morgan Stanley Global Healthcare Conference
August 26 2019 - 9:00AM
Business Wire
ResMed (NYSE: RMD) (ASX: RMD) today announced that David
Pendarvis, chief administrative officer and global general counsel,
will participate in a fireside chat at the 17th Annual Morgan
Stanley Global Healthcare Conference on Monday, September 9, 2019,
beginning at approximately 2:50 p.m. (Eastern Time) at the Grand
Hyatt New York in New York City.
More information about this event, including a live webcast, may
be accessed by visiting http://investor.resmed.com. The webcast
replay will be available approximately one hour after the live
webcast ends and will be accessible for approximately 90 days
following the conference.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our cloud-connected medical
devices transform care for people with sleep apnea, COPD and other
chronic diseases. Our comprehensive out-of-hospital software
platforms support the professionals and caregivers who help people
stay healthy in the home or care setting of their choice. By
enabling better care, we improve quality of life, reduce the impact
of chronic disease, and lower costs for consumers and healthcare
systems in more than 120 countries. To learn more, visit ResMed.com
and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190826005121/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024